Alamar Biosciences(ALMR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ALMR Alamar Biosciences

Trading 05-13 13:46:15 EDT

23.59

+0.62

+2.68%

High24.88	Low22.80	Vol111.86K
Open22.99	D1 Closing22.97	Amplitude9.06%
Mkt Cap1.63B	Tradable Cap221.11M	Total Shares69.31M
T/O2.69M	T/O Rate1.19%	Tradable Shares9.38M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ALMR","market":"US","secType":"STK","nameCN":"Alamar Biosciences","latestPrice":23.585,"timestamp":1778694368919,"preClose":22.97,"halted":0,"volume":111856,"delay":0,"changeRate":0.026774053112755856,"floatShares":9375000,"shares":69311200,"eps":-0.627,"marketStatus":"Trading","change":0.615,"latestTime":"05-13 13:46:15 EDT","open":22.99,"high":24.88,"low":22.8,"amount":2687024.4068,"amplitude":0.090553,"askPrice":23.74,"askSize":400,"bidPrice":23.56,"bidSize":19,"shortable":3,"etf":0,"ttmEps":-0.627,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1778702400000},"marketStatusCode":2,"adr":0,"listingDate":1776398400000,"exchange":"NASDAQ","adjPreClose":22.97,"preHourTrading":{"tag":"盘前","latestPrice":22.97,"preClose":22.97,"latestTime":"09:29 EDT","volume":160,"amount":3719.82,"timestamp":1778678943111,"change":0,"changeRate":0,"amplitude":0.032216},"postHourTrading":{"tag":"盘后","latestPrice":22.97,"preClose":22.97,"latestTime":"19:52 EDT","volume":613,"amount":14124.776,"timestamp":1778629929567,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.73036},"requestUrl":"/m/hq/s/ALMR/","defaultTab":"news","newsList":[{"id":"2635249336","title":"Alamar Biosciences initiated with an Outperform at Leerink","url":"https://stock-news.laohu8.com/highlight/detail?id=2635249336","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635249336?lang=en_us&edition=fundamental","pubTime":"2026-05-13 01:01","pubTimestamp":1778605270,"startTime":"0","endTime":"0","summary":"Leerink initiated coverage of Alamar Biosciences (ALMR) with an Outperform rating and $35 price target Core to the firm’s thesis is the differentia...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alamar-biosciences-initiated-with-an-outperform-at-leerink-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alamar-biosciences-initiated-with-an-outperform-at-leerink-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634210956","title":"BofA Initiates Alamar Biosciences at Neutral With $27 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2634210956","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634210956?lang=en_us&edition=fundamental","pubTime":"2026-05-12 22:11","pubTimestamp":1778595077,"startTime":"0","endTime":"0","summary":"Price: 24.78, Change: +0.90, Percent Change: +3.77","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634165602","title":"Alamar Biosciences, Inc. : Bofa Global Research Initiates Coverage With  Neutral Rating and Price Objective $27.00","url":"https://stock-news.laohu8.com/highlight/detail?id=2634165602","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634165602?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:50","pubTimestamp":1778586640,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nAZN4SVOVY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALMR","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634215820","title":"Stifel Initiates Alamar Biosciences at Buy With $28 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2634215820","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634215820?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:24","pubTimestamp":1778585094,"startTime":"0","endTime":"0","summary":"Stifel Initiates Alamar Biosciences at Buy With $28 Price Target","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ALMR","SF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634218378","title":"Alamar Biosciences Initiated at Buy by Stifel","url":"https://stock-news.laohu8.com/highlight/detail?id=2634218378","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634218378?lang=en_us&edition=fundamental","pubTime":"2026-05-12 18:55","pubTimestamp":1778583300,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALMR/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 12, 2026 06:55 ET (10:55 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4127","BK4121","ALMR","SF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634902872","title":"Alamar Biosciences Inc : TD Cowen Initiates Coverage With Buy Rating; Price Target $30","url":"https://stock-news.laohu8.com/highlight/detail?id=2634902872","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634902872?lang=en_us&edition=fundamental","pubTime":"2026-05-12 18:44","pubTimestamp":1778582642,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nFWN41P10V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALMR","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634297881","title":"Alamar Biosciences Inc : Leerink Partners Initiates Coverage With Outperform Rating; Target Price $35","url":"https://stock-news.laohu8.com/highlight/detail?id=2634297881","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634297881?lang=en_us&edition=fundamental","pubTime":"2026-05-12 18:04","pubTimestamp":1778580257,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nFWN41P106:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634129286","title":"Alamar Biosciences initiated with a Buy at TD Cowen","url":"https://stock-news.laohu8.com/highlight/detail?id=2634129286","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634129286?lang=en_us&edition=fundamental","pubTime":"2026-05-12 17:36","pubTimestamp":1778578592,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Dan Brennan initiated coverage of Alamar Biosciences (ALMR) with a Buy rating and $30 price target The company’s Nulisa chemistry ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alamar-biosciences-initiated-with-a-buy-at-td-cowen-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alamar-biosciences-initiated-with-a-buy-at-td-cowen-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4207","BK4566","BK4121","TD","ALMR","COWN","BK4127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634729964","title":"Alamar Biosciences initiated with an Overweight at JPMorgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2634729964","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634729964?lang=en_us&edition=fundamental","pubTime":"2026-05-12 16:41","pubTimestamp":1778575284,"startTime":"0","endTime":"0","summary":"JPMorgan analyst Casey Woodring initiated coverage of Alamar Biosciences (ALMR) with an Overweight rating and $30 price target Alamar is a proteomi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alamar-biosciences-initiated-with-an-overweight-at-jpmorgan-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alamar-biosciences-initiated-with-an-overweight-at-jpmorgan-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALMR","PGF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634299602","title":"Alamar Biosciences initiated with a Buy at Stifel","url":"https://stock-news.laohu8.com/highlight/detail?id=2634299602","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634299602?lang=en_us&edition=fundamental","pubTime":"2026-05-12 16:40","pubTimestamp":1778575245,"startTime":"0","endTime":"0","summary":"Stifel initiated coverage of Alamar Biosciences (ALMR) with a Buy rating and $28 price target Alamar is an emerging multiplex proteomics player tha...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alamar-biosciences-initiated-with-a-buy-at-stifel-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alamar-biosciences-initiated-with-a-buy-at-stifel-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALMR","BK4121","BK4127","SF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634298415","title":"U.S. RESEARCH ROUNDUP-Accuray, Aevex, Zoetis","url":"https://stock-news.laohu8.com/highlight/detail?id=2634298415","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634298415?lang=en_us&edition=fundamental","pubTime":"2026-05-12 15:21","pubTimestamp":1778570494,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Accuray, Aevex, ZoetisMay 12 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Accuray, Aevex and Zo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nL4N41P0LT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0476273544.USD","VCTR","APO","CEVA","HIMY","LU0106831901.USD","LU0345781412.USD","CYTK","CGNX","PLNT","ZTS","ARAY","KKR","VSNT","CVS","MOS","LU2458330169.SGD","ALMR","PSIX","ASTH","CE","SGI","SKYE","TXG","GTM","ARES","BAM","ELVN","TGT","BX","LENZ","LU2089985449.USD","HMYY","SIBN","SPG","HIMS","FTV","LQDA","BK4106","AVEX","BK4216","HIMZ","TOST","TRGP","SNDA","AMAT","HIYY","AGM","BILL","WPC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633456291","title":"Alamar Biosciences Q1 Loss Widens, Revenue Rises","url":"https://stock-news.laohu8.com/highlight/detail?id=2633456291","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633456291?lang=en_us&edition=fundamental","pubTime":"2026-05-08 20:28","pubTimestamp":1778243320,"startTime":"0","endTime":"0","summary":"Alamar Biosciences  reported a Q1 loss Friday of $1.74 per diluted share, widening from a loss of $0.68 a year earlier.Revenue for the quarter ended March 31 was $26 million, up from $13.1 million a year earlier.As of March 31, the company had cash, cash equivalents, and restricted cash of $69.5 million.Shares of the company were up 2.4% in Friday's premarket activity.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633455171","title":"Earnings Flash (ALMR) Alamar Biosciences Posts Q1 Net Loss $1.74 a Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2633455171","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633455171?lang=en_us&edition=fundamental","pubTime":"2026-05-08 20:04","pubTimestamp":1778241871,"startTime":"0","endTime":"0","summary":"Earnings Flash (ALMR) Alamar Biosciences Posts Q1 Net Loss $1.74 a Share","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633455458","title":"Alamar Biosciences Q1 FY26 net loss widens to $21.3 million; revenue rises 99% to $26 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633455458","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633455458?lang=en_us&edition=fundamental","pubTime":"2026-05-08 20:03","pubTimestamp":1778241795,"startTime":"0","endTime":"0","summary":"Alamar Biosciences posted Q1 revenue of USD 26 million, up 99% year over year.Net loss widened to USD 21.3 million; operating loss widened to USD 12.3 million.Gross margin rose to 56%, up 7 percentage points; operating expenses climbed 79% to USD 26.8 million on higher personnel costs, product-offering expansion, legal costs, accounting costs.Consumables revenue more than doubled to USD 14 million; instrument revenue rose 78% to USD 7.4 million.Raised about USD 220 million in gross IPO proceeds in April; plans to issue full-year 2026 revenue guidance with Q2 results in August.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nNDL6KssWl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","LU2210149790.SGD","BK4121","NDAQ","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","SG9999014005.SGD","SG9999014021.USD","BK4585","LU2095319765.USD","IE00BKPKM429.USD","IE00B64PRP62.GBP","BK4588","SG9999014039.USD","ALMR","SG9999014013.SGD","IE00BN0W2V16.EUR","LU2210150020.SGD","BK4112","IE00BN0W2W23.USD","IE00BN0W2T93.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633552064","title":"Alamar Biosciences Inc - Cash and Equivalents $69.5 Mln as of March 31, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2633552064","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633552064?lang=en_us&edition=fundamental","pubTime":"2026-05-08 20:00","pubTimestamp":1778241601,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nTUABR7QKZ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633455203","title":"Alamar Biosciences: Q1 EPS $-1.74","url":"https://stock-news.laohu8.com/highlight/detail?id=2633455203","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633455203?lang=en_us&edition=fundamental","pubTime":"2026-05-08 20:00","pubTimestamp":1778241601,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nTUABR7QKZ:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633201455","title":"Alamar Biosciences Inc - Q1 2026 Revenue Rises to $26.0 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2633201455","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633201455?lang=en_us&edition=fundamental","pubTime":"2026-05-08 20:00","pubTimestamp":1778241601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nTUABR7QKZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633556264","title":"Press Release: Alamar Biosciences Reports First Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2633556264","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633556264?lang=en_us&edition=fundamental","pubTime":"2026-05-08 20:00","pubTimestamp":1778241600,"startTime":"0","endTime":"0","summary":"FREMONT, Calif., May 08, 2026  -- Alamar Biosciences, Inc. , a leader in Precision Proteomics dedicated to enabling the earliest detection of disease, today reported financial results for the quarter ended March 31, 2026.-- Generated $26.0 million of total revenue for the first quarter of 2026,an increase of 99% as compared to the corresponding period of 2025.-- Launched two new products, NULISAseq Neuro 220 Panel and. Operating expenses were $26.8 million for the first quarter of 2026, a 79% increase from $14.9 million for the corresponding prior-year period. The year-over-year increase in operating expenses was primarily related to increased personnel costs, increased costs related to expansion of our product offerings, and increased professional costs for legal and accounting services.Operating loss was $12.3 million for the first quarter of 2026, as compared to an operating loss of $8.6 million for the corresponding prior-year period. This includes $1.5 million of stock-based compe","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","BK4121","ALMR","BK4099","BK4555","TM","03160","BK4604"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633262549","title":"Alamar Biosciences to present at BofA Securities 2026 Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2633262549","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633262549?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:12","pubTimestamp":1778011930,"startTime":"0","endTime":"0","summary":"Alamar Biosciences to present at BofA Securities 2026 Healthcare Conference on May 12 in Las Vegas.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nNDL7sc6YC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0130518102.USD","SG9999014013.SGD","LU0256863811.USD","IE00BN0W2V16.EUR","BK4207","LU0053666078.USD","LU0234570918.USD","LU0321505439.SGD","LU0106831901.USD","LU0648000940.SGD","LU0648001328.SGD","LU1804176565.USD","LU0320765489.SGD","IE00BZ1G4Q59.USD","LU2095319765.USD","LU0052756011.USD","BK4504","IE00BKVL7J92.USD","LU0256863902.USD","IE00B64PRP62.GBP","LU0098860793.USD","LU0306806265.USD","LU1880398471.USD","LU2265009873.SGD","IE00BLSP4452.SGD","LU1366192091.USD","BK4588","LU1894683348.USD","LU1894683264.USD","ALMR","LU2129689514.USD","LU0321505868.SGD","LU2129689605.HKD","LU2210150020.SGD","LU0971096721.USD","LU0306807586.USD","LU1496350171.SGD","LU0310800965.SGD","LU0203345920.USD","LU0640476718.USD","NDAQ","LU0170899867.USD","LU1718418525.SGD","SG9999014021.USD","IE00B7SZLL34.SGD","IE00BBT3K403.USD","BAC","IE00BN0W2W23.USD","LU0417517546.SGD","LU1883839398.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632932017","title":"Biotech firm Odyssey targets $810 million valuation in US IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2632932017","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632932017?lang=en_us&edition=fundamental","pubTime":"2026-05-04 18:48","pubTimestamp":1777891715,"startTime":"0","endTime":"0","summary":"UPDATE 2-Biotech firm Odyssey targets $810 million valuation in US IPOAdds details throughout. May 4  - Biopharmaceutical company Odyssey Therapeutics said on Monday it is targeting a valuation of up to $809.9 million in its initial public offering in the United States, as investors warm up to drug developers. The Boston-based company is seeking to raise up to $238.3 million by offering 13.2 million shares priced between $16 and $18 apiece. The U.S. IPO market has made a strong comeback in recent weeks, setting the stage for a pickup in listings in coming months.Last month, weight-loss drug developer Kailera Therapeutics KLRA.O, Alamar Biosciences ALMR.O and nuclear reactor maker X-Energy XE.O made stellar market debuts.April marked the biggest month for new filings in more than four years, according to Renaissance Capital, a provider of IPO-focused research and ETFs. This despite a volatile first quarter amid a sell-off in tech stocks, private credit strains and the Middle East confli","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nL4N41H0NW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVDS","ANV","NVDS.UK","LU0158827948.USD","LU2420271590.USD","ALMR","NVIW.SI","BK4533","LU0345768740.USD","XE","NVDA","NVD","LU2236285917.USD","NVDU","2NVD.UK","LU1934455277.USD","SGXZ23171101.USD","LU2756315664.SGD","LU1989772923.USD","KLRA","LU0724617625.USD","NVII","LU0345768153.USD","NVDL","NVDQ","SNVD.UK","NVDO","NVDG","LU0965509283.SGD","LU2552382132.HKD","LU0061474705.USD","NVDB","NVD3.UK","NVDD","NVDW","DIPS","NVDY","LU1803068979.SGD","SGXZ81514606.USD","NVDX","IE000YTNTUN2.SGD","LU0265550359.USD","NVD2.UK","LU0310799852.SGD","LU1267930490.SGD","LU1153585028.USD","LU0072462426.USD","BK4532","3NVD.UK","IE00B3SWFQ91.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.alamarbio.com","stockEarnings":[{"period":"1week","weight":-0.0389},{"period":"1month","weight":0.3512},{"period":"ytd","weight":0.3512}],"compareEarnings":[{"period":"1week","weight":0.0199},{"period":"1month","weight":0.0864},{"period":"3month","weight":0.0668},{"period":"6month","weight":0.0984},{"period":"1year","weight":0.2662},{"period":"ytd","weight":0.0825}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"exchange":"NASDAQ","name":"Alamar Biosciences","nameEN":"Alamar Biosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Alamar Biosciences(ALMR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Alamar Biosciences(ALMR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Alamar Biosciences,ALMR,Alamar Biosciences股票,Alamar Biosciences股票老虎,Alamar Biosciences股票老虎国际,Alamar Biosciences行情,Alamar Biosciences股票行情,Alamar Biosciences股价,Alamar Biosciences股市,Alamar Biosciences股票价格,Alamar Biosciences股票交易,Alamar Biosciences股票购买,Alamar Biosciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Alamar Biosciences(ALMR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Alamar Biosciences(ALMR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}